CLINICAL TRIAL SUMMARY

MDACC Study No:2013-0097 (clinicaltrials.gov NCT No: NCT01854554)
Title:A prospective Phase II randomized trial to compare intensity modulated proton radiotherapy (IMPT) vs. intensity modulated radiotherapy (IMRT) for newly diagnosed Glioblastoma (WHO Grade IV)
Principal Investigator:Paul Brown
Treatment Agent:Intensity Modulated Radiotherapy; Proton Therapy
Study Status:Open
Study Description:The goal of this clinical research study is to compare IMRT with IMPT in
patients with glioblastoma. Researchers want to learn about cognitive side
effects (mental status changes) that may occur, such as memory loss and
impaired thinking.

IMRT is the delivery of focused radiation therapy using photon beams and
advanced computer planning to help shape the dose in order to give the highest
possible dose to the tumor with the least dose to surrounding normal tissues.

IMPT is also focused radiation therapy similar to IMRT, but it uses proton
particles to deliver the radiation instead of photon beams. IMPT also uses
advanced computer planning in order to shape the dose to the target with the
least dose to surrounding normal tissues.

Hide details for General InformationGeneral Information

Disease Group:Brain
Phase of Study:Phase II
Treatment Agents:Intensity Modulated Radiotherapy
Proton Therapy
Treatment Location:Only at MDACC
Estimated Length of Stay in Houston:
Supported By:MD Anderson Cancer Center
Return Visit:
Home Care:


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Paul Brown
Dept:Radiation Oncology
For Clinical Trial Enrollment:713-563-2300
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults